Finance

Lists
Why is ASTH down 2.92%?
Dive Deeper
ASTH:NASDAQ
Astrana Health Inc
$30.84
-2.92%
(-0.93) 1D
Nov 13, 11:09:00 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ASTH...
Open
$31.61
High
$32.66
Low
$30.84
Mkt. cap
1.58B
Avg. vol.
360.64K
Volume
31.74K
52-wk high
$51.59
52-wk low
$18.08
Beta
1.18
Shares outstanding
49.60M
No. of employees
3K
Open
$31.61
High
$32.66
Low
$30.84
Mkt. cap
1.58B
Avg. vol.
360.64K
Volume
31.74K
52-wk high
$51.59
52-wk low
$18.08
Beta
1.18
Shares outstanding
49.60M
No. of employees
3K
News stories
From web sources and news partners
About Astrana Health Inc
CEO-
Employees3K
Founded1985
HeadquartersAlhambra, California, United States
SectorHealth Care
IndustryHealth care provider
Websiteastranahealth.com
Analyst ratings
Based on 6 analysts giving stock ratings to ASTH in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ASTH in the last 3 months.
Highest
Current $30.84
$53.00 (+71.84%)
Average
$51.50 (+66.98%)
Lowest
$50.00 (+62.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
$50.00
+62.1%
11/09/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
11/09/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$53.00
+71.8%
11/06/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Reiterated
$50.00
+62.1%
10/01/2026
Jailendra Singh
Truist Financial
Buy
Maintained
-
-
09/29/2026
Michael Wiederhorn
Oppenheimer
Buy
Initiated
$53.00
+71.8%
09/15/2026
David Larsen
BTIG
Buy
Maintained
$65.00
+110.8%
08/09/2026
Matthew Shea
Needham
Buy
Reiterated
$41.00
+32.9%
08/07/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/06/2026
Jack Slevin
Jefferies
Buy
Reiterated
$53.00
+71.8%
06/30/2026
Michael Craig Jones
Bank of America Securities
Buy
Maintained
-
-
05/13/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$45.00
+45.9%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
950.53M
965.10M
972.52M
1.02B
Cost of goods sold
855.48M
859.36M
868.50M
900.07M
Cost of revenue
855.48M
859.36M
868.50M
900.07M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.05M
61.16M
54.15M
68.05M
Operating expense
77.45M
76.64M
69.70M
83.67M
Total operating expenses
932.93M
935.99M
938.20M
983.74M
Operating income
17.60M
29.11M
34.32M
39.88M
Other non operating income
2.10M
662.00K
-2.30M
1.23M
EBT including unusual items
7.51M
19.71M
27.21M
32.22M
EBT excluding unusual items
2.34M
19.21M
22.48M
31.10M
Income tax expense
944.00K
6.58M
8.76M
11.95M
Effective tax rate
12.58%
33.38%
32.19%
37.10%
Other operating expenses
-
-
-
-
Net income
6.00M
14.44M
19.74M
12.95M
Net profit margin
0.63%
1.50%
2.03%
1.27%
Earnings per share
0.42
0.74
0.80
0.71
Interest and investment income
3.99M
3.82M
5.91M
4.15M
Interest expense
-22.52M
-16.10M
-16.00M
-15.02M
Net interest expenses
-18.53M
-12.28M
-10.09M
-10.87M
Depreciation and amortization charges
16.40M
15.48M
15.55M
15.62M
EBITDA
34.00M
44.59M
49.87M
55.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps